Cigna Group (NYSE:CI) Receives Consensus Rating of "Buy" from Analysts

Key Points

• Analysts have given Cigna Group a consensus rating of "Buy", with 15 out of 19 analysts recommending the stock as a buy or strong buy.
• Cigna reported $7.20 EPS for the last quarter, exceeding estimates, and achieved a revenue of $67.13 billion, marking an 11% year-over-year increase.
• The company declared a quarterly dividend of $1.51 per share, with a dividend yield of 2.0%, set to be paid on September 18th.

Shares of Cigna Group (NYSE:CI - Get Free Report) have been assigned a consensus recommendation of "Buy" from the nineteen analysts that are currently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have assigned a strong buy rating to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $374.8235.

CI has been the subject of a number of recent research reports. Deutsche Bank Aktiengesellschaft set a $415.00 target price on shares of Cigna Group and gave the stock a "buy" rating in a report on Tuesday, August 5th. Barclays dropped their price target on Cigna Group from $385.00 to $354.00 and set an "overweight" rating on the stock in a research note on Friday, August 1st. TD Cowen upgraded Cigna Group to a "strong-buy" rating in a research note on Monday, June 23rd. Piper Sandler boosted their price target on Cigna Group from $348.00 to $374.00 and gave the stock an "overweight" rating in a research note on Monday, May 5th. Finally, Wells Fargo & Company dropped their price target on Cigna Group from $341.00 to $340.00 and set an "equal weight" rating on the stock in a research note on Thursday, August 14th.

Cigna Group Stock Performance

Shares of Cigna Group stock opened at $300.8270 on Tuesday. The company has a market capitalization of $80.30 billion, a PE ratio of 16.42, a P/E/G ratio of 0.89 and a beta of 0.47. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The company has a 50-day simple moving average of $300.64 and a two-hundred day simple moving average of $311.79. Cigna Group has a one year low of $256.89 and a one year high of $370.83.

Cigna Group (NYSE:CI - Get Free Report) last announced its earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping analysts' consensus estimates of $7.15 by $0.05. The business had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm's revenue was up 11.0% on a year-over-year basis. During the same period in the previous year, the company posted $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Research analysts expect that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th will be paid a dividend of $1.51 per share. The ex-dividend date is Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. Cigna Group's payout ratio is presently 32.97%.

Insider Buying and Selling at Cigna Group

In other news, insider Nicole S. Jones sold 28,526 shares of the business's stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the sale, the insider owned 25,648 shares in the company, valued at approximately $7,694,400. The trade was a 52.66% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.70% of the company's stock.

Institutional Investors Weigh In On Cigna Group

A number of large investors have recently modified their holdings of CI. Cim Investment Management Inc. boosted its position in Cigna Group by 99.6% in the second quarter. Cim Investment Management Inc. now owns 3,705 shares of the health services provider's stock valued at $1,124,000 after buying an additional 1,849 shares during the last quarter. Pathway Financial Advisers LLC boosted its position in Cigna Group by 2.3% in the second quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider's stock valued at $496,000 after buying an additional 34 shares during the last quarter. B. Riley Wealth Advisors Inc. purchased a new stake in Cigna Group in the second quarter valued at approximately $1,030,000. MRP Capital Investments LLC boosted its position in Cigna Group by 196.8% in the second quarter. MRP Capital Investments LLC now owns 920 shares of the health services provider's stock valued at $304,000 after buying an additional 610 shares during the last quarter. Finally, Advisory Services Network LLC boosted its position in Cigna Group by 18.1% in the second quarter. Advisory Services Network LLC now owns 5,167 shares of the health services provider's stock valued at $1,708,000 after buying an additional 792 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company's stock.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.